
    
      PRIMARY OBJECTIVE:

      To assess feasibility and biodistribution of PET imaging in malignancy using 68Ga-FAPI.

      OUTLINE:

      Patients receive 68Ga-FAPI intravenously (IV) and then undergo PET/CT approximately 1 hour
      later.

      After completion of study, patients are followed up at 24-72 hours.
    
  